Cargando…

Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling

Fetal growth restriction (FGR) is a major cause of poor perinatal outcomes. Although several studies have been conducted to improve the prognosis of FGR in infants, no effective intrauterine treatment method has been established. This study aimed to use tadalafil, a phosphodiesterase 5 inhibitor (PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Kayo, Tanaka, Hiroaki, Tachibana, Ryota, Yoshikawa, Kento, Kawamura, Takuya, Takakura, Sho, Takeuchi, Hiroki, Ikeda, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835936/ https://www.ncbi.nlm.nih.gov/pubmed/35163395 http://dx.doi.org/10.3390/ijms23031474

Ejemplares similares

Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
por: Tsuchiya, Kyoka, et al.
Publicado: (2020)

Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring
por: Kawamura, Takuya, et al.
Publicado: (2021)

Placental growth factor level is correlated with intrapartum fetal heart rate findings
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions
por: Tachibana, Ryota, et al.
Publicado: (2019)

Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction
por: Tsuji, Makoto, et al.
Publicado: (2023)

Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
por: Maki, Shintaro, et al.
Publicado: (2020)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
por: Tanaka, Hiroaki, et al.
Publicado: (2019)

Carboxylated Poly-L-lysine Potentially Reduces Human Sperm DNA Fragmentation after Freeze-Thawing, and Its Function Is Enhanced by Low-Dose Resveratrol
por: Tachibana, Ryota, et al.
Publicado: (2023)

Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report
por: Sakamoto, Mito, et al.
Publicado: (2016)

TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial
por: Umekawa, Takashi, et al.
Publicado: (2018)

The Successful Use of Nitroglycerin for Uterine Hyperstimulation with Fetal Heart Rate Abnormality Caused by a Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS): A Case Report
por: Takakura, Sho, et al.
Publicado: (2021)

Placental mTOR complex 1 regulates fetal programming of obesity and insulin resistance in mice
por: Akhaphong, Brian, et al.
Publicado: (2021)

Carboxylated Poly-l-Lysine as a Macromolecular Cryoprotective Agent Enables the Development of Defined and Xeno-Free Human Sperm Cryopreservation Reagents
por: Takeuchi, Hiroki, et al.
Publicado: (2021)

Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
por: Gong, Sungsam, et al.
Publicado: (2018)

Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)
por: Maki, Shintaro, et al.
Publicado: (2022)

GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway
por: Lai, Wei-Si, et al.
Publicado: (2019)

Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental Dysfunction
por: de Alwis, Natasha, et al.
Publicado: (2022)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial
por: Maki, Shintaro, et al.
Publicado: (2019)

Diet‐induced obesity in mice reduces placental efficiency and inhibits placental mTOR signaling
por: Lager, Susanne, et al.
Publicado: (2014)

Does the Biological Response to Fetal Hypoxia Involve Angiogenesis, Placental Enlargement and Preeclampsia?
por: Eskild, Anne, et al.
Publicado: (2016)

Inhibition of placental mTOR signaling provides a link between placental malaria and reduced birthweight
por: Dimasuay, Kris Genelyn, et al.
Publicado: (2017)

Placental Remote Control of Fetal Metabolism: Trophoblast mTOR Signaling Regulates Liver IGFBP-1 Phosphorylation and IGF-1 Bioavailability
por: Rosario, Fredrick J., et al.
Publicado: (2023)

Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Placental Aromatase Is Deficient in Placental Ischemia and Preeclampsia
por: Perez-Sepulveda, Alejandra, et al.
Publicado: (2015)

Role of the Placental Vitamin D Receptor in Modulating Feto-Placental Growth in Fetal Growth Restriction and Preeclampsia-Affected Pregnancies
por: Murthi, Padma, et al.
Publicado: (2016)

Maternal folate deficiency causes inhibition of mTOR signaling, down-regulation of placental amino acid transporters and fetal growth restriction in mice
por: Rosario, Fredrick J., et al.
Publicado: (2017)

Placental Mitochondrial Abnormalities in Preeclampsia
por: Vangrieken, Philippe, et al.
Publicado: (2021)

Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice
por: Grace, Matthew R., et al.
Publicado: (2019)

Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
por: Beetch, Megan, et al.
Publicado: (2021)

Impact of placental mTOR deficiency on peripheral insulin signaling in adult mice offspring
por: Beetch, Megan, et al.
Publicado: (2023)

Accurate evaluation of the progress of delivery with transperineal ultrasound may improve vaginal delivery: a single-center retrospective study
por: Enomoto, Naosuke, et al.
Publicado: (2023)

Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia
por: Devarshi, Prasad P., et al.
Publicado: (2019)

The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia(†)
por: Wat, Jovian M, et al.
Publicado: (2020)

Protein Profiling of Preeclampsia Placental Tissues
por: Shu, Chang, et al.
Publicado: (2014)

Oxidative Stress in Preeclampsia and Placental Diseases
por: Aouache, Rajaa, et al.
Publicado: (2018)

Disruption of Placental Homeostasis Leads to Preeclampsia
por: Nakashima, Akitoshi, et al.
Publicado: (2020)

Placental Mitochondrial Function and Dysfunction in Preeclampsia
por: Jahan, Fahmida, et al.
Publicado: (2023)

Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin
por: Kida, Teruyo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1sdcaao6f41hcfmpbphniseuap